Misha Rosenbach,
Karolyn A. Wanat,
Robert G. Micheletti,
Laura A. Taylor
e.a.
Springer International Publishing
e druk, 2018
9783319184487
Inpatient Dermatology
Specificaties
Gebonden, blz.
|
Engels
Springer International Publishing |
2018
ISBN13: 9783319184487
Rubricering
Levertijd ongeveer 9 werkdagen
Gratis verzonden
Samenvatting
Inpatient Dermatology is a concise and portable resource that synthesizes the most essential material to help physicians with recognition, differential diagnosis, work-up, and treatment of dermatologic issues in the hospitalized patient.
Complete with hundreds of clinical and pathologic images, this volume is both an inpatient dermatology atlas and a practical guide to day-one, initial work-up, and management plan for common and rare skin diseases that occur in the inpatient setting.
Each chapter is a bulleted, easy-to-read reference that focuses on one specific inpatient dermatologic condition, with carefully curated clinical photographs and corresponding histopathologic images to aid readers in developing clinical-pathologic correlation for the dermatologic diseases encountered in the hospital. Before each subsection the editors share diagnostic pearls, explaining their approach to these challenging conditions. This book is structured to be useful to physicians, residents, and medical students. It spans dermatology, emergency medicine, internal medicine, infectious disease, and rheumatology. Inpatient Dermatology is the go-to guide for hospital-based skin diseases, making even the most complex inpatient dermatologic issues approachable and understandable for any clinician.
Specificaties
ISBN13:9783319184487
Taal:Engels
Bindwijze:gebonden
Uitgever:Springer International Publishing
Inhoudsopgave
Preface <p>Part I: Introduction </p> <p>Chapter 1. General Principles and Approach to Inpatient Dermatology</p> <p></p>in;mso-hansi-theme-font:major-latin;mso-bidi-font-family: "Times New Roman"">DIVIDER<p></p> <p>Part II: Medication reactions<br/> Chapter 2. Morbilliform drug eruption</p> <p>Chapter 3. Urticaria</p> ound-image: initial; Chapter 4. Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis <p></p> <p>Chapter 5. Erythema</p> Multiforme<p></p> <p>Chapter 6. Drug Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms </p> <p>Chapter 7. Acute Generalized Exanthematous Pustulosis </p> <p></p>pt;line-height: 115.0%;Chapter 8. Fixed Drug Eruption<p></p> oNormal">Chapter 9. Serum Sickness-like Reaction <p></p> <p>DIVIDER</p> <p>Part III. Oncodermatology: Cancer- and treatment-related skin issues </p> <p></p>uot;,"serif";mso-ascii-theme-font:major-latin;mso-hansi-theme-font: major-latin;mso-bidi-Chapter 10. Sweet Syndrome<p></p> <p>Chapter 11. Leukemia Cutis</p> <p></p>ily: Cambria , serif;">Chapter 12. Toxic Erythema of Chemotherapy<p></p> aChapter 13. Neutrophilic Eccrine Hidradenitis <p></p> <p>Chapter 14. Transient acantholytic dermatosis</p>pan style="font-size: 9pt; line-height: 115%; font-family: Cambria, serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;"> of Chemotherapy<p></p> <p></p>amily: Cambria , serif;">Chapter 15. <p></p>repeat: initial; background-attachment: initial; background-origin: initial; background-clip: Serpentine Supravenous Hyperpigmentation<p></p> <p>Chapter 16. Epidermal Growth Fa</p>ctor Inhibitors<p></p> <p>Chapter 17. Bleomycin-induced flagellate erythema</p>bidi-font-family: "Times New Roman""><p></p> <p></p>9.0pt;line-Chapter 18. Graft-Versus-Host Disease: Acute <p></p> <p></p>e: 9.0pt;line-heiChapter 19. Graft-Versus-Host Disease: Chronic <p></p> <p>DIVIDER</p>t-size:9.0pt;line-height:115%; font-family:"Cambria","serif";mso-ascii-theme-font:major-latin;mso-hansi-theme-font: major-latin">[KH1] Infections and Infestations<p></p> <p>Part IV. Infections: Bacterial</p> <p></p>ine-height: 115.0%;font-family: Cambria , serif;">Chapter 20. Superficial Staphylococcal and Streptococcal Infections <p></p> New Roman";mso-bidi-theme-font:major-bidi; background:yellow;mso-highlight:yellow"><p></p> <p>Chapter 21. Cellulitis</p> <p>Chap</p>ter 22. Necrotizing fasciitis <p></p> <p>Chapter 23. Staphylococcal scalded skin syndrome </p>st-font-family: "Times New Roman";mso-fareast-theme-font:major-fareast;mso-hansi-theme-font: major-latin;mso-bidi-font-family:"Times New Roman";mso-bidi-theme-font:major-bidi; mso-ansi-lang<p></p> class="MsoNormal">Chapter 24. Echthyma Gangrenosum<p></p> <p></p>mes New Roman";mso-bidi-theme-font:major-bidi; mso-ansi-languageChapter 25. Purpura Fulminans<p></p> <p>Chapter 26. Meningococcal Infections</p> <p>Chapter 27. </p>yle="font-size: 9pt; line-height: 115%; font-family: Cambria, serif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Atypical mycobacteria<p></p> al"><p></p>mes New Roman";msoChapter 28. Lyme disease<p></p> <p>Chapter 29. Spotted Fever </p> <p>Chapter 30. Syphilis</p> ="MsoNormal">Part V. Infections: Viral<p></p> <p>Chapter 31. Herpes simplex virus </p> <p></p>amily: Cambria , serif;">Chapter 32. Eczema Herpeticum<p></p> <p></p>font-size:9.0pt;line-height:115%; font-family:"Cambria","serif";mso-ascii-theme-font:major-latin;mso-hansi-theme-font: major-latin;mso-bidi-font-family:"Times New Roman";mso-ansi-language:Chapter 33. Varicella zoster virus<p></p> <p>Chapter 34. Coxsackie virus: Hand-Foot-Mouth Disease </p> <p>Chapter 35. </p>: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Human Immunodeficiency Virus <p></p> <p></p>mbria , serif;">Chapter 36. Kaposi’s Sarcoma <p></p> <p></p>="FR" style="font-size:9.0pt;line-height:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-foPart VI. Infections: Fungal<p></p> <p>Chapter 37. Superficial Dermatophyte / Tinea </p> <p>Chapter 38. Candidiasis </p> <p></p>ine-height:115%; font-family:"Cambria","serif";mso-ascii-theme-font:major-latin;mso-hansi-theme-font: major-latin;mso-bidi-font-family:"Times New Roman";mso-ansi-language:FR">Chapter 39. Angioinvasive Fungal infections<p></p><p></p> <p>Chapter 40. Histoplas</p>mosis<p></p> <p>Chapter 41. Coccidiodomycosis</p> <p></p>ot;Cambria","serif";mso-ascii-theme-font:major-latin;mso-hansi-theme-font: major-latin;mso-bidi-font-family:"TimesChapter 42. Blastomycosis<p></p> <p>Chapter 43. Cryptococcosis</p> <p>Part VII. Infections: Ectoparasitic Infestations</p> <p></p>erif";mso-ascii-theme-font:major-latin;mso-hansi-theme-font: major-latin;mso-bidi-font-family:"Times New Roman";mso-ansi-language:FR">Chapter 44. Scabies<p></p> <p>Chapter 45. Lice</p> <p>Chapter 46. Be</p>d Bugs <p></p>/p> <p></p>eight:115%;font-family:"Cambria","serif"; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: "Times New Roman";mso-ansi-language:FR">DIVIDER<p></p> <p>Part VIII. Purpura: Vasculitis and Vasculopathy</p>i-font-family:Arial;mso-ansi-language: FR"><p></p> <p> </p> <p></p>t: 115.0%;font-family: Cambria , serif;">Chapter 47. Leukocytoclastic Vasculitis / Cutaneous small vessel vasculi<p></p>tis <p></p> ><p></p>pChapter 48. Granulomatosis with Polyangiitis <p></p> <p></p>me-font:major-latin; mso-bidi-font-family:"Times New Roman"Chapter 49. Eosinophilic Granulomatosis with Polyangiitis <p></p> <p>Chapter 50. Microscopic Polyangiitis</p> New Roman";mso-fareast-theme-font:major-fareast; mso-hansi-theme-font:major-latin;mso-bidi-font-family:"Times New Roman"; mso-bidi-theme-font:major-bidi"><p></p> <p>Chapter 51. </p>if;">Pol<p></p><p></p>yarteritis Nodosa <p></p> soNormal">Chapter 52. Giant Cell Arteritis <p></p> <p>Chapter 53. Cholesterol Emboli </p> <p>Chapter 54. </p>rif; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial;">Infective Endocarditis<p></p> <p></p>, serif;">Chapter 55. Cryoglobulinemia <p></p> ">;<p></p>t: major-latin;mso-bidi-font-family:"Times New Roman";mso-ansi-language:FRChapter 56. Antiphospholipid Antibody Syndrome <p></p> <p>Chapter 57. Calciphylaxis </p> <p>Chapter 58. </p>rigin: initial; background-clip: initial;">Levamisole-Associat<p></p> <p>DIVIDER</p> <p>Part IX. Erythoderma</p> MsoNormal">t: 115.0%;font-family: Cambria , serif;">Chapter 59. ">Medication-Induced Erythroderma <p></p> ">"font-size: 9.0pt;line-height: 115.0%;font-family: Cambria , serif;">Chapter 60. Atopic Dermatitis and Erythroderma <p></p> <p></p>major-latin;mso-hansi-theme-font: major-latin;mso-bidi-font-family:"Times New Roman";mso-ansi-language:FR">Chapter 61. Psoriasis <p></p> <p></p>: 115.0%;font-family: Cambria , serif;">Chapter 62. Cutaneous T-Cell Lymphoma <p></p> <p>Chapter 63. </p>tial; background-origin: initial; background-clip: initial;">Pityriasis Rubra Pilaris <p></p> <p></p>R" styDIVIDER<p></p> <p></p>; mso-ascii-theme-font:major-latin;mso-hansi-theme-font:major-latin;mso-bidi-font-family: "Times New Roman";mso-ansi-language:FR">Part X. Inflammatory and Autoimmune Conditions<p></p> <p></p>;"> <p></p> <p></p>idi-foChapter 64. Pyoderma Gangrenosum <p></p> <p>Chapter 65. Panniculitis / Erythema nodosum </p> <p>Chapter 66. Lichen Planus </p> <p></p>uot;,"serif";mso-ascii-theme-font:major-latin;mso-hansi-theme-font: major-latin;mso-bidi-font-family:"Times New Roman";mso-ansi-language:FR">Chapter 67. Dermatomyositis <p></p> ">="FR" style="font-size: 9.0pt;line-height: 115.0%;font-family: Cambria , serif;">Chapter 68. Lupus <p></p> <p></p>Chapter 69. <p></p>es New Roman"">Bullous Pemphigoid <p></p> <p>Chapter 70. Pemphigus Foliaceus </p> <p>Chapter 71. Pemphigus Vulgaris </p> <p></p>Chapter 72. <p></p> <p></p> Roman";mso-bidi-theme-font:major-bidi">Chapter 73. Dermatitis Herpetiformis <p></p> <p></p>ine-height: 115.0%;font-family: Cambria , serif;">Chapter 74. Systemic Sclerosis <p></p> <p></p>Chap<p></p>ter 75. Systemic Amyloidosis <p></p> <p></p>di-font-family:"Times New Roman""> <p></p> <p>DIVIDER</p> <p>Part XI: Hospital-Related Skin Problems</p>Times New Roman"; mso-hansi-theme-font:major-latin;mso-bidi-font-family:Arial"><p></p> <p></p>style="font-size: 9.0pt;line-heigh <p></p> <p></p>%;font-family: Cambria , serif;">Chapter 76. Stasis Dermatitis <p></p> <p></p>t: 115.0%;font-family: Cambria , serif;">Chapter 77. Miliaria <p></p> <p></p><p></p>ine-height:115%;font-family: "Cambria","serif";mso-ascii-theme-fontChapter 78. Decubitus Ulcers<p></p> <p>Chapter 79. Inte</p>rtrigo <p></p> <p>Chapter 80. Contact Dermatitis </p> <p></p>i-font-family:"Times New Roman"">Chapter 81. Edema Blisters <p></p> <p></p>Chapter 82. Steroid Acne<p></p><div><div></div></div>